Gilles Peytavin

33PUBLICATIONS
57CO-AUTHORS
Environmental epidemiologyGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsPharmacogenomicsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 23, 2026
Drug-Drug Interaction Between Praziquantel and Nevirapine in HIV-Schistosomiasis Co-infection: A Pharmacokinetic case report.

|Jun 22, 2026
Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program a.

|Jun 22, 2026
Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|May 22, 2026
Drug interactions and kidney safety of bictegravir/emtricitabine/tenofovir alafenamide in kidney transplant recipients with HIV: an interventional pilot study.

|Feb 15, 2026
HBV reactivation after switching to cabotegravir plus rilpivirine therapy among people living with HIV: do not forget the reservoir.

Rémi Rouget, Sophie Seang, Marion Favier

Pageof 6

Frequent Collaborators

12 joint publications

Minh-Patrick Le

5 joint publications

Jade Ghosn

5 joint publications

Quentin Le Hingrat

4 joint publications

Marc Wirden